Please assess the completion status of the following clinical trial:

Trial Title: Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient's written informed consent. Adequate cognitive capacity.~* Adequate family support~* No acute diverticulitis episode in the last 3 months~* mNeff 0 acute diverticulitis (abdominal computed tomography scan)~* No antibiotic treatment in the last 2 weeks~* Immunocompetence\*~* No significant comorbidities\*\*~* Good oral tolerance~* Good symptom control~* Maximum one of the following SIRS criteria (\* T\>38 ºC or \<36ºC, L\>12,000 or \<4000/uL, HR\>90 bpm, RR\<20 rpm) or CRP\>15 mg/dL~Exclusion Criteria:~* Women in pregnancy or breastfeeding~* Age \<18 years or \> 80 years.~* Absence of the patient's written informed consent. Inadequate cognitive capacity.~* Inadequate family support~* Acute diverticulitis episode in the last 3 months~* Moderate acute diverticulitis (mNeff grade I or upper)~* Antibiotic treatment in the last 2 weeks~* Inflammatory bowel disease~* Immunodepression\*~* Presence of significant comorbidities\*\*~* Bad oral tolerance~* Poor symptom control~* More than one of the following SIRS criteria (\* T\>38 ºC or \<36ºC, L\>12,000 or \<4000/uL, HR\>90 bpm, RR\<20 rpm) or CRP\>15 mg/dL~(\*) Immunocompetence is the absence and immunodepression is the presence of any of the following: active neoplastic disease/hematologic malignancy/HIV with low CD4+ count/long-term corticosteroid treatment/immunosuppressant therapy/transplant/splenectomy/genetic immunodeficiency.~(\*\*) We consider significant comorbidities any of the following: poorly controlled diabetes mellitus (HbA1\>7mg/dl), cardiologic event in the last 3 months, decompensation of hepatopathy in the last 3 months, renal chronic insufficiency in dialysis programme.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Symptomatic treatment with NSAID (Type: EXPERIMENTAL): 1 g/8 h acetaminophen alternating with 600 mg/8 h ibuprofen
- Antibiotic+symptomatic treatment with NSAID (Type: ACTIVE_COMPARATOR): 875/125mg /8h amoxicillin/clavulanic acid and symptomatic treatment with 1 g/8 h acetaminophen alternating with 600 mg/8 h ibuprofen

Based on this trial design, predict the completion outcome and termination type (if applicable).